单位(元)鹏华医药科技股票A(001230)利润表 |
报告期 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
收入 |
155,424,569 |
-267,583,599 |
-246,593,046 |
-194,856,223 |
利息收入 |
6,733,467 |
2,668,477 |
3,652,564 |
2,401,570 |
其中:存款利息收入 |
2,400,568 |
1,085,627 |
1,126,908 |
584,945 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
4,332,900 |
1,582,851 |
2,525,656 |
1,816,625 |
投资收益 |
-58,740,504 |
9,226,070 |
-37,425,670 |
-104,210,303 |
其中:股票投资收益 |
-76,356,217 |
-2,693,326 |
-47,622,824 |
-110,139,710 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
- |
- |
- |
- |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
17,615,712 |
11,919,396 |
10,197,153 |
5,929,407 |
公允价值变动收益 |
199,955,303 |
-284,465,999 |
-214,213,904 |
-93,900,628 |
汇兑收益 |
- |
- |
- |
- |
其他收入 |
7,476,304 |
4,987,853 |
1,393,964 |
853,137 |
费用 |
61,411,707 |
30,947,229 |
29,325,993 |
14,555,456 |
管理人报酬 |
49,868,502 |
25,789,737 |
24,926,493 |
12,371,457 |
托管费 |
8,311,417 |
4,298,290 |
4,154,416 |
2,061,910 |
销售服务费 |
2,968,232 |
734,769 |
- |
- |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
263,557 |
124,433 |
245,085 |
122,089 |
利润总额 |
94,012,862 |
-298,530,827 |
-275,919,040 |
-209,411,679 |
减:所得税费用 |
- |
- |
- |
- |
净利润 |
94,012,862 |
-298,530,827 |
-275,919,040 |
-209,411,679 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。